Document is current

Any future updates will be listed below

<scp>eEF</scp> 2K—a new target in breast cancers with combined inactivation of p53 and PTEN

Crossref DOI link: https://doi.org/10.15252/emmm.201404683

Published Online: 2014-12-03

Published Print: 2014-12

Update policy: https://doi.org/10.1002/crossmark_policy

About CrossMark